W23
1 Woolworths Way, Bella Vista, NSW, 2153, Australia
Overview
W23 invest in game-changing startups led by visionary founders, and actively help them achieve their ambitious plans faster.
- Total investments
- 9
- Lead investments
- 3
- Investments · 12mo
- 2
- Active investors
- 1
Investment portfolio
- Moment Energy
Participated · Series B · May 2026
Moment Energy extracts EV battery modules, replaces automakers’ battery management systems with its own software, and packages diverse chemistries into modular, UL-certified grid storage solutions. The company emphasizes safety and modularity to improve insurability, uptime, and compatibility with future battery advances. Moment has supply agreements with Mercedes-Benz and Nissan and serves customers that include utilities, industrial firms, and data centers. It employs around 72 people and has raised over $100 million in total funding, including a recent $40 million Series B and a $20 million loan from the U.S. Department of Energy. Moment is building a gigawatt-scale factory in Austin, Texas to scale production and deployment.
- Keychain
Led · Equity · Nov 2025
Keychain provides an end-to-end, AI-driven manufacturing and product-development platform for the consumer packaged goods sector. Its newest module, Keychain360, integrates product design, sourcing, manufacturing and compliance into one operating system, allowing retailers to cut product development timelines by months and gain real-time visibility across their supplier networks. The company’s technology is already used by eight of the world’s ten largest retailers, plus 7-Eleven, Whole Foods and seven of the top ten CPG brands, touching more than 30,000 manufacturers and 20,000 brands and retailers. A recent deployment with a top-ten retailer enabled the launch of over 100 products while reducing time-to-market by two months. Since founding less than two years ago, Keychain has launched three products (KeychainOS for manufacturers, its core platform, and now Keychain360) and entered the Irish and UK markets. It previously closed a $30 million Series B round and continues to expand aggressively as private-label demand grows. The company is headquartered in New York and aspires to create the next generation of connected product development for global retail.
- Auror
Led · Series C · Nov 2024
Auror offers a retail crime reporting and intelligence platform that helps retailers detect, report, and prevent theft and other crimes. The platform collects and analyzes data from video surveillance, self-checkout AI, and in-store alerts. Its system is used by over 150,000 retail users across 45,000 stores globally, including Coles, Woolworths, Bunnings, Marks & Spencer and BP. Auror raised NZ$82.0M in a Series C to support its growth and R&D plans. The company intends to use the funds to expand in North America and the UK and to drive further research and development. Investors leading the round include Axon Enterprise, W23 Global and Reinventure, with support from existing investors. Auror offers a crime intelligence platform used by frontline store employees, headquarters staff and police to prevent organized crime, reduce shrink and make store employees safer. The company was founded nine years ago by Phil Thomson, Tom Batterbury and James Corbett and honed its offering in New Zealand, capturing over 80% of retailers by spend there before expanding to Australia and the US. Auror takes a privacy-by-design approach, avoiding CCTV and live facial recognition while enabling structured incident reporting and secure data sharing. Its product enables retailer-to-retailer collaboration and aggregates data for police to prioritize investigations. Named customers include Walmart, Woolworths, Coles, The Warehouse and Z Energy, and customer feedback in the investment notes is highly enthusiastic. The combination of easy frontline reporting, trusted sharing and police aggregation creates multiple layers of network effects and a flywheel that increases reporting and investigative effectiveness as Auror expands into the US.
- ExoFlare
Participated · Seed · Jul 2024
ExoFlare has launched after two years in stealth to deliver a new class of biosecurity infrastructure for farmers, transporters, processors, retailers and international markets. Its platform integrates expert knowledge, AI including predictive machine learning, sensing, and genomics-based diagnostics to accelerate detection, response and recovery from biological threats. The software is already used on ~700 sites across seven agriculture industry groups in Australia and the Indo, with more than 235,000 comprehensive biosecurity risk assessments completed. ExoFlare positions its product to deliver business continuity, market-access assurances, and operational efficiencies while enabling structured data sharing with governments for faster responses to incursions. The company emphasizes protecting the world’s $10 trillion food system and developing biosecurity threat management as a new export industry for Australia. It also reports engagement and partnerships with agricultural R&D bodies including AgriFutures Australia, Australian Pork Limited, CSIRO (including Data61), and Meat & Livestock Australia, as well as federal and state government departments.
- Eucalyptus
Participated · Equity · Apr 2023
Eucalyptus sells medical products online across multiple demographic-focused consumer brands, operating through online and text-based consultations that can result in prescribed treatments. Its core brands are Pilot (men’s health), Juniper (women’s weight loss and menopause), Kin (fertility) and Software (prescription skincare); it previously launched and later offloaded a sex-toy brand called Normal. The company emphasizes moving from transactional care toward more comprehensive chronic-disease management, and CEO Tim Doyle says some programs (for example Juniper) include many patient touch points—20 in the first month. Eucalyptus was founded in 2019 by Tim Doyle, Benny Kleist, Alexey Mitko and Charlie Gearside. The business has faced media and medical-community scrutiny over marketing and telehealth prescribing practices, and rivals such as Mosh operate a similar online consultation model. Financially, it has completed multiple funding rounds and most recently raised capital at a reported $520 million valuation. Eucalyptus is a fast-growing Sydney-based online health start-up that provides digital health services. The company has recently attracted significant external capital, raising $60 million in a funding round. Management is evaluating the potential to bring new obesity-management and weight-loss drugs to the Australian market. The raise signals investor confidence in Eucalyptus’s growth trajectory and strategy to expand its clinical offerings. Beyond the new drug plans, the company continues to operate as a digital health platform serving patients online. Eucalyptus operates a vertically integrated telehealth platform that runs four demographic-focused brands, each with its own providers, patient data repository, remote monitoring tools and partner integrations. The company serves more than 200,000 patients and positions itself as a private-pay, direct-to-consumer option in Australia, sometimes charging lower copays than the average $25 doctor visit. Founded in 2019, Eucalyptus has grown rapidly—more than tripling last year—and expects similar growth this year while expanding headcount. The new funding will support product development and the creation of a digital-health portfolio for primary care, with plans to push deeper into chronic care areas such as diabetes, heart conditions and mental health. Over the next year the company intends to introduce new brands around behavioral health, weight management and diabetes to build a hub for ongoing chronic-care touch points. Eucalyptus operates as a consumer brand builder and platform that launches digital products, with two active telehealth brands: Pilot (targeted at young men) and Kin (a subscription contraceptive service for women). The founders—Tim Doyle, Benny Kleist, Alexey Mitko, and Charlie Gearside—moved into telehealth after personal negative healthcare experiences and prior work together at mattress startup Koala. The company is exploring additional consumer verticals and is currently investigating skincare and elderly healthcare with the aim to launch two new brands by the end of the year. Eucalyptus expects to leverage Woolworths' product development and consumer data capabilities to accelerate future brand launches. The business has raised multiple funding rounds to date and counts repeat backer Blackbird among its investors.
Team
Ingrid Maes
Managing Director
LinkedIn